Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Enfamil LIPIL adds soy

This article was originally published in The Tan Sheet

  • News

Executive Summary

Enfamil ProSobee LIPIL - soy infant formula fortified with nutritional oils DHA, ARA - began shipping Dec. 3, Mead Johnson says. ProSobee will be available in ready-to-use, powder, concentrate forms, BMS division says. As with other LIPIL products, ProSobee is priced 15% higher than non-fortified formulas. Ross Products also plans to launch a fortified soy formula this month (1"The Tan Sheet" Nov. 4, 2002, In Brief)...

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

EU Launches Critical Medicines Alliance But Prospect Of Act On Manufacturing Still Uncertain

‘Shocking’ MHRA Performance & Poor Data Transparency Blamed For UK’s Clinical Trial Crisis

Updated COVID-19 Vaccines Should Target New JN.1 Variant, Says EMA

EMA Pilots Partnering With Companies To Gain Efficiencies In Preparing Drug Assessment Reports

See All
UsernamePublicRestriction

Register

PS094872

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By